AMRX
Price:
$16.21
Market Cap:
$5.17B
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-07
Stock Exchange
NASDAQ
Ticker
AMRX
According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 43.81. This represents a change of -56.94% compared to the average of 101.75 of the last 4 quarters.
The mean historical PE Ratio of Amneal Pharmaceuticals, Inc. over the last ten years is 10.70. The current 43.81 PE Ratio has changed 40.84% with respect to the historical average. Over the past ten years (40 quarters), AMRX's PE Ratio was at its highest in in the September 2025 quarter at 333.67. The PE Ratio was at its lowest in in the September 2024 quarter at -4160.00.
Average
10.70
Median
3.16
Minimum
-20.84
Maximum
68.43
Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 828.35%
Maximum Annual PE Ratio = 68.43
Minimum Annual Increase = -798.87%
Minimum Annual PE Ratio = -20.84
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 54.78 | -362.85% |
| 2024 | -20.84 | 64.81% |
| 2023 | -12.65 | 446.50% |
| 2022 | -2.31 | -103.38% |
| 2021 | 68.43 | 828.35% |
| 2020 | 7.37 | -798.87% |
| 2019 | -1.05 | -89.63% |
| 2018 | -10.17 | -189.20% |
| 2017 | 11.40 | -5.32% |
| 2016 | 12.05 | -74.65% |
The current PE Ratio of Amneal Pharmaceuticals, Inc. (AMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.10
5-year avg
17.48
10-year avg
10.70
Amneal Pharmaceuticals, Inc.’s PE Ratio is greater than Lantheus Holdings, Inc. (24.67), greater than Supernus Pharmaceuticals, Inc. (-86.78), greater than Indivior Pharmaceuticals Inc (19.05), greater than Telix Pharmaceuticals Limited (-451.71), greater than Perrigo Company plc (-0.78), greater than Soleno Therapeutics, Inc. (27.09), greater than Mirum Pharmaceuticals, Inc. (-7.87), less than Envista Holdings Corp (61.69), greater than Bausch Health Companies Inc. (-1.49), greater than Dyne Therapeutics, Inc. (-6.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| 24.67 | $6.76B | |
| -86.78 | $2.58B | |
| 19.05 | $4.78B | |
| -451.71 | $3.42B | |
| -0.78 | $1.42B | |
| 27.09 | $2.76B | |
| -7.87 | $5.38B | |
| 61.69 | $4.22B | |
| -1.49 | $1.78B | |
| -6.15 | $3.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Amneal Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the highest PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 3-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 5-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
How does the current PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX) compare to its historical average?